Merit Medical Systems reported $416.24M in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
3M USD 6.58B 84M Sep/2026
Abbott USD 13.01B 423M Sep/2026
AngioDynamics USD 79.43M 3.72M Sep/2025
Anika Therapeutics USD 30.62M 2.8M Dec/2025
AtriCure USD 154.45M 850K Sep/2026
Baxter International USD 2.98B 20M Sep/2026
Becton, Dickinson and Co. USD 5.3B 300M Sep/2026
Boston Scientific USD 5.14B 300M Sep/2026
Cooper Companies USD 1.07B 15.3M Jun/2026
Dexcom USD 1.34B 30M Sep/2026
Edwards Lifesciences USD 1.72B 20M Sep/2026
Globus Medical USD 763.72M 25.89M Sep/2026
Haemonetics USD 357.76M 18.76M Sep/2026
ICU Medical USD 556.22M 4.54M Sep/2026
Insulet USD 842M 40.3M Sep/2026
Integra LifeSciences USD 411.18M 7.62M Sep/2026
J&J USD 25.4B 89M Sep/2026
Medtronic USD 9.8B 0 Jun/2026
Merit Medical Systems USD 416.24M 2.56M Sep/2026
Olympus JPY 269.19B 28.79B Sep/2026
Pfizer USD 16.6B 1.57B Sep/2026
STAAR Surgical USD 83.4M 10.1M Sep/2026
Stryker USD 6.5B 100M Sep/2026
Tandem Diabetes Care USD 283.69M 29.09M Sep/2026
Teleflex USD 567.8M 2.5M Sep/2026
Terumo JPY 312.69B 881M Sep/2026
Zimmer Biomet Holdings USD 2.06B 120M Sep/2026